Postoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factors
暂无分享,去创建一个
H. Honda | Y. Shioyama | T. Nakashima | T. Yoshitake | Katsumasa Nakamura | S. Ohga | K. Ohnishi | H. Hirata | Tomonari Sasaki | M. Shinoto | K. Asai | N. Kunitake | Y. Higaki
[1] Hongyu Yang,et al. Salivary duct carcinoma of the parotid gland: A case report and review of the literature , 2014, Oncology letters.
[2] S. Nam,et al. Treatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glands. , 2012, The British journal of radiology.
[3] S. Kim,et al. Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients , 2012, Neuroradiology.
[4] A. Mäkitie,et al. Management and outcome of salivary duct carcinoma in major salivary glands , 2012, European Archives of Oto-Rhino-Laryngology.
[5] S. Piao,et al. Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma , 2012, Journal of Cancer Research and Clinical Oncology.
[6] P. Slootweg,et al. Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G. De Riu,et al. Management of midcheek masses and tumors of the accessory parotid gland. , 2011, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[8] R. Weber,et al. Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance , 2010, Clinical Cancer Research.
[9] Y. Ko,et al. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[10] S. Takashima,et al. Salivary duct carcinoma of the parotid gland: clinical and MR features in six patients. , 2009, The British journal of radiology.
[11] J. Roh,et al. Prognostic values of pathologic findings and hypoxia markers in 21 patients with salivary duct carcinoma , 2008, Journal of surgical oncology.
[12] J. Sercarz,et al. Salivary duct carcinoma: A clinical and histologic review with implications for trastuzumab therapy , 2007, Head & neck.
[13] R. Dodd,et al. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. , 2006, Oral oncology.
[14] T. Löning,et al. Clinical and immunohistologic typing of salivary duct carcinoma , 2005, Cancer.
[15] R. Valeri,et al. Salivary Duct Carcinoma of the Parotid Gland , 2005, Acta Cytologica.
[16] S. Pambuccian,et al. Salivary Duct Carcinoma , 1998, Acta Cytologica.
[17] C. Grandi,et al. Salivary duct carcinoma: Clinical characteristics and treatment strategies , 1997, Head & neck.
[18] A. Garden,et al. The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. , 1995, International journal of radiation oncology, biology, physics.
[19] C. Colmenero Ruiz,et al. Salivary duct carcinoma: a report of nine cases. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[20] W. Hong,et al. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.